StockData
GENELUX Corp logo

GENELUX Corp (GNLX) stock

GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$1.92+0.05 (+2.95%)

Close on Nov 16, 2026Market cap $86.87MP/E –Yield –

Genelux profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Genelux's profit margin for the twelve months ending Dec 31, 2024 was -373362.5%. For fiscal 2025 it was -401812.5%, against -373362.5% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-401812.5%−28450.0
FY2024Dec 31, 2024-373362.5%−356717.2
FY2023Dec 31, 2023-16645.3%−16598.2
FY2022Dec 31, 2022-47.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2024Mar 31, 2024-98125.0%–
Q1 FY2023Mar 31, 2023-6096.5%–
Q4 FY2022Dec 31, 2022-5139.7%–
Q3 FY2022Sep 30, 202244.6%–

More Genelux figures

See a number that looks wrong?